Vor Biopharma Inc. (VOR) - Dilution Analysis

10-Q filing | 54.2M shares outstanding

8-K filing: Vor Biopharma Inc. entered into a Securities Purchase Agreement to issue and sell 5,338,078 shares of common stock at $14.05 per share, for gross proceeds of $75.0 million, in a private placement with entities affiliated with TCGX, with the closing expected on March 30, 2026, resulting in 54,185,582 shares of common stock outstanding post-closing. ($75.0M proceeds)

S-3 filing: This prospectus relates to the proposed resale from time to time by the selling stockholders named herein of up to an aggregate of 13,876,032 shares of our common stock, all of which were issued by us at the closing of a private placement on December 18, 2025.

10-Q filing | 10.4M shares outstanding

S-3/A filing: This prospectus relates to the proposed resale from time to time by the selling stockholders named herein of up to an aggregate of 50,999,999 shares of our common stock.

S-3 filing: This prospectus relates to the proposed resale from time to time by the selling stockholders of up to an aggregate of 50,999,999 shares of our common stock issuable upon the exercise of outstanding warrants.

10-Q filing | 125.3M shares outstanding

10-Q filing | 124.8M shares outstanding

10-K filing | 124.9M shares outstanding

S-3 filing: The company may offer and sell up to $350,000,000 of any combination of common stock, preferred stock, debt securities and warrants.

S-3 filing: This prospectus relates to the proposed resale from time to time by the selling stockholders of up to an aggregate of 125,710,335 shares of our common stock, which consists of (i) 55,871,260 shares of our common stock held by the selling stockholders, or the PIPE Shares, and (ii) 69,839,075 shares of our common stock issuable upon the exercise of outstanding warrants, or the Warrants, to purchase shares of our common stock held by the selling stockholders.

10-Q filing | 68.5M shares outstanding

10-Q filing | 68.3M shares outstanding

10-Q filing | 68.0M shares outstanding

10-K filing | 67.2M shares outstanding

10-Q filing | 67.6M shares outstanding

10-Q filing | 67.0M shares outstanding

10-Q filing | 66.3M shares outstanding

10-K filing | 66.4M shares outstanding

S-3 filing: This is an S-3 filing registering the offer and sale of common stock by selling stockholders.

10-Q filing | 38.0M shares outstanding

10-Q filing | 37.4M shares outstanding

10-Q filing | 37.6M shares outstanding

10-K filing | 37.5M shares outstanding

S-3 filing: The filing is for a mixed shelf offering of common stock, preferred stock, and debt securities with a total value of up to $350,000,000 and an ATM offering of common stock with a value of up to $125,000,000.

10-Q filing | 37.3M shares outstanding

10-Q filing | 37.1M shares outstanding

10-Q filing | 37.1M shares outstanding